Barrett EsophagusSymptoms, Doctors, Treatments, Advances & More
Learn About Barrett Esophagus
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Srinadh Komanduri is a Gastroenterologist in Chicago, Illinois. Dr. Komanduri has been practicing medicine for over 29 years and is rated as an Elite provider by MediFind in the treatment of Barrett Esophagus. His top areas of expertise are Barrett Esophagus, Bile Duct Obstruction, Cholestasis, Endoscopy, and Pancreatectomy.
BIDMC - Division Of Gastroenterology/GI West
Douglas Pleskow is an Internal Medicine provider in Boston, Massachusetts. Dr. Pleskow has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Barrett Esophagus. His top areas of expertise are Choledocholithiasis, Barrett Esophagus, Bile Duct Obstruction, Endoscopy, and Colonoscopy.
Baylor College Of Medicine - Gastroenterology
Hashem El-Serag, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Hashem El-Serag specializes in Gastroenterology and works at Baylor College of Medicine Gastroenterology. To make an appointment, please call (713) 798-2500. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Serag is rated as an Elite provider by MediFind in the treatment of Barrett Esophagus. His top areas of expertise are Liver Cancer, Hepatitis C, Barrett Esophagus, Endoscopy, and Colonoscopy.
Summary: This phase II trial studies the effect of obeticholic acid in treating patients with Barrett's esophagus. Bile acids present in duodenogastroesophageal reflux contribute to neoplastic progression in Barrett's esophagus. Obeticholic acid has shown anti-cholestatic, anti-inflammatory and anti-fibrotic effects mediated by FXR activation. It down regulates bile acid availability and decreases proinfla...
Summary: This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.